Enhanced COVID-19 Transparency Act of 2025

# Enhanced COVID-19 Transparency Act of 2025 - Summary **What the Bill Would Do** The Enhanced COVID-19 Transparency Act of 2025 (S 3291) aims to increase public disclosure of information related to the COVID-19 pandemic. While specific provisions aren't detailed in the available information, bills with this title typically focus on requiring government agencies and possibly private entities to release additional documents, data, and communications about pandemic response decisions, vaccine development, public health guidance, and other coronavirus-related activities. **Who It Affects and Current Status** This bill would primarily affect federal health agencies (such as the CDC and FDA), government officials involved in pandemic response, and potentially the public seeking access to pandemic-related information. The bill is currently in committee, meaning it has been introduced but not yet debated or voted on by the full Senate.

It was sponsored by Senator Todd Young (R-IN). Without additional legislative details publicly available, the specific scope of required disclosures and their impact on individuals or organizations cannot be fully determined at this time.